These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
343 related items for PubMed ID: 1354782
1. Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young. Velho G, Froguel P, Clement K, Pueyo ME, Rakotoambinina B, Zouali H, Passa P, Cohen D, Robert JJ. Lancet; 1992 Aug 22; 340(8817):444-8. PubMed ID: 1354782 [Abstract] [Full Text] [Related]
2. High prevalence of glucokinase mutations in Italian children with MODY. Influence on glucose tolerance, first-phase insulin response, insulin sensitivity and BMI. Massa O, Meschi F, Cuesta-Munoz A, Caumo A, Cerutti F, Toni S, Cherubini V, Guazzarotti L, Sulli N, Matschinsky FM, Lorini R, Iafusco D, Barbetti F, Diabetes Study Group of the Italian Society of Paediatic Endocrinology and Diabetes (SIEDP). Diabetologia; 2001 Jul 22; 44(7):898-905. PubMed ID: 11508276 [Abstract] [Full Text] [Related]
3. Specific insulin and proinsulin secretion in glucokinase-deficient individuals. Pardini VC, Velho G, Reis R, Purisch S, Blanché H, Vieira JG, Moisés RC. Braz J Med Biol Res; 1999 Apr 22; 32(4):427-30. PubMed ID: 10347805 [Abstract] [Full Text] [Related]
5. Lilly Lecture 1994. The beta-cell in diabetes: from molecular genetics to clinical research. Polonsky KS. Diabetes; 1995 Jun 22; 44(6):705-17. PubMed ID: 7789637 [Abstract] [Full Text] [Related]
6. Diabetes complications in NIDDM kindreds linked to the MODY3 locus on chromosome 12q. Velho G, Vaxillaire M, Boccio V, Charpentier G, Froguel P. Diabetes Care; 1996 Sep 22; 19(9):915-9. PubMed ID: 8875082 [Abstract] [Full Text] [Related]
7. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. Froguel P, Zouali H, Vionnet N, Velho G, Vaxillaire M, Sun F, Lesage S, Stoffel M, Takeda J, Passa P. N Engl J Med; 1993 Mar 11; 328(10):697-702. PubMed ID: 8433729 [Abstract] [Full Text] [Related]
8. Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state. Tripathy D, Carlsson AL, Lehto M, Isomaa B, Tuomi T, Groop L. Diabetologia; 2000 Dec 11; 43(12):1476-83. PubMed ID: 11151756 [Abstract] [Full Text] [Related]
10. Caudal regression syndrome in a fetus of a glucokinase-maturity-onset diabetes of the young pregnancy. Taylor RAM, Mackie A, Mogra R, Pinner J, Rajendran S, Ross GP. Diabet Med; 2019 Feb 11; 36(2):252-255. PubMed ID: 30362177 [Abstract] [Full Text] [Related]
11. Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. Byrne MM, Sturis J, Clément K, Vionnet N, Pueyo ME, Stoffel M, Takeda J, Passa P, Cohen D, Bell GI. J Clin Invest; 1994 Mar 11; 93(3):1120-30. PubMed ID: 8132752 [Abstract] [Full Text] [Related]
12. Incretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential. Østoft SH. Dan Med J; 2015 Sep 11; 62(9):. PubMed ID: 26324089 [Abstract] [Full Text] [Related]
20. A novel glucokinase gene mutation and its effect on glycemic/C-peptide fluctuations in a patient with maturity-onset diabetes of the young type 2. Loomba-Albrecht LA, Jame M, Bremer AA. Diabetes Res Clin Pract; 2010 Mar 11; 87(3):e23-5. PubMed ID: 20015564 [Abstract] [Full Text] [Related] Page: [Next] [New Search]